We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Supercooling Extends Liver Preservation for Transplantation

By HospiMedica International staff writers
Posted on 13 Jul 2014
A new preservation technique dramatically increases the amount of time organs could remain viable outside of the body. More...


Developed by researchers at Massachusetts General Hospital (MGH; Boston, USA), the preservation technique has tripled the amount of time that rat livers can be stored before transplantation. The first step involves perfusion of the liver to supercool the tissue without causing irreversible damage to the cells using 3-O-methyl-D-glucose (3-OMG), a nontoxic, modified glucose compound that acts as a protectant against the cold. The solution also includes polyethylene glycol (PEG-35kD, the active ingredient in antifreeze), to specifically protect cell membranes and lower the freezing point of a solution.

The rat livers were then slowly cooled further to below freezing point, reaching -6 °C without inducing freezing, thereby maintaining organ suitable for preservation. Using this new technique, the researchers were able to store the supercooled rat livers for up to 96 hours. After storing the organs for up to four days, the researchers again used machine perfusion to rewarm the organ, while also delivering oxygen and other nutrients to prepare it for transplantation.

All the rats who were implanted with the supercooled livers stored for three days survived three months; the survival rate for animals receiving livers stored for four days was 58%. When testing to see if all the steps in their method were essential, the researchers found that if they eliminated the supplemental components PEG-35kD or 3-OMG, none of the rats survived for even a week. If they did not use machine perfusion or supercooling, death occurred within an hour of transplantation. The study was published online on June 29, 2014, in Nature Medicine.

“We have shown that each of these components is individually required to achieve viable supercooling preservation in our model, as evidenced by long-term recipient survival,” concluded lead author Martin Yarmush, MD, PhD, and colleagues. “To our knowledge, supercooling is the first preservation technique capable of rendering livers transplantable after four days of storage. As extensive screening of different additives or variations in protocol is still ongoing, additional improvements could be achieved from future experimentation.”

Current technology can preserve livers outside the body for a maximum of 24 hours using a combination of cold temperatures and a chemical solution developed by scientists at the University of Wisconsin-Madison in 1983. The solution helps keep the liver tissue from dying while in transit to the recipient site. The difficulty with long-term preservation of human organs stems mostly from the extensive tissue damage that occurs when organs are frozen. While successful for single cells and simple tissues, the problem is exacerbated with whole organs because of the multiple cell types and other structures that react differently to cold.

Related Links:

Massachusetts General Hospital 



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.